You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

NIMODIPINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Nimodipine

A generic version of NIMODIPINE was approved as nimodipine by HERITAGE on May 2nd, 2007.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NIMODIPINE?
  • What are the global sales for NIMODIPINE?
  • What is Average Wholesale Price for NIMODIPINE?
Drug patent expirations by year for NIMODIPINE
Drug Prices for NIMODIPINE

See drug prices for NIMODIPINE

Recent Clinical Trials for NIMODIPINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Xiaolin Chen, MDPhase 2/Phase 3
Acasti Pharma Inc.Phase 3
Fukuang General Hospital of Liaoning health industry groupPhase 3

See all NIMODIPINE clinical trials

Pharmacology for NIMODIPINE
Medical Subject Heading (MeSH) Categories for NIMODIPINE
Paragraph IV (Patent) Challenges for NIMODIPINE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
NYMALIZE Oral Solution nimodipine 6 mg/mL 203340 1 2021-11-29

US Patents and Regulatory Information for NIMODIPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bionpharma NIMODIPINE nimodipine CAPSULE;ORAL 076740-001 Jan 17, 2008 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Inds Inc NIMODIPINE nimodipine CAPSULE;ORAL 077067-001 Apr 17, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Heritage NIMODIPINE nimodipine CAPSULE;ORAL 077811-001 May 2, 2007 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.